3
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effect of COVID-19 on maternal and neonatal services

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Similar to the observations made by Ashish KC and colleagues 1 in Nepal, we previously reported an increase in stillbirths associated with the COVID-19 pandemic in the UK, from 2·38 per 1000 births (between Oct 1, 2019, and Jan 31, 2020) to 9·31 per 1000 births (between Feb 1 and June 14, 2020), but unrelated to clinical severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. 2 This observation has been sustained, with the number of stillbirths remaining high in July, 2020 (14·2 per 1000 births). In media reports, this observation has been made in other UK hospitals. However, stillbirths are primarily antenatal in the UK. By including only women at 22 weeks' gestation or more and with confirmed fetal heart sounds, KC and colleagues extend our findings to less-resourced settings and show an increase in confirmed intrapartum stillbirths associated with a reduction in quality of care during the pandemic. Because the reported increase in stillbirths might be an underestimate of the true indirect effect of the pandemic on perinatal survival, information is needed on the incidence of antenatal stillbirth in the study settings used by KC and colleagues. The increase in intrapartum stillbirths and reduction in intrapartum quality of care make unsurprising an increase in neonatal mortality, because some infants will die from neonatal sequelae of intrapartum insults that are resistant to basic neonatal care. Moreover, KC and colleagues have documented an increase in preterm births during the pandemic, associated with lockdown and a reduction in care seeking for birth. Although an increase in preterm births has been observed in studies of pregnancies in women with COVID-19, 3 this was primarily iatrogenic, making an increase related solely to asymptomatic SARS-CoV-2 infection less likely. If the rate of ultrasonography-dated pregnancies changed during the pandemic, this could have contributed to estimates of lower gestational age at birth. To assess this, information is needed on any differences in antenatal screening during the pandemic and lockdown in particular, something that was preserved in 85% of sites in the UK. 4 We agree that pandemic lockdowns have potentially harmful effects. 5 The reductions in care seeking and their associations with adverse outcomes observed in Nepal and in the UK serve to emphasise the need for balanced public health messaging.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic

          This study compares pregnancy outcomes, including rates of stillbirth (fetal death ≥24 weeks’ gestation), preterm and cesarean delivery, and neonatal unit admission in the months preceding vs during the 2020 COVID-19 pandemic at a London university hospital.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study

            Summary Background The COVID-19 pandemic response is affecting maternal and neonatal health services all over the world. We aimed to assess the number of institutional births, their outcomes (institutional stillbirth and neonatal mortality rate), and quality of intrapartum care before and during the national COVID-19 lockdown in Nepal. Methods In this prospective observational study, we collected participant-level data for pregnant women enrolled in the SUSTAIN and REFINE studies between Jan 1 and May 30, 2020, from nine hospitals in Nepal. This period included 12·5 weeks before the national lockdown and 9·5 weeks during the lockdown. Women were eligible for inclusion if they had a gestational age of 22 weeks or more, a fetal heart sound at time of admission, and consented to inclusion. Women who had multiple births and their babies were excluded. We collected information on demographic and obstetric characteristics via extraction from case notes and health worker performance via direct observation by independent clinical researchers. We used regression analyses to assess changes in the number of institutional births, quality of care, and mortality before lockdown versus during lockdown. Findings Of 22 907 eligible women, 21 763 women were enrolled and 20 354 gave birth, and health worker performance was recorded for 10 543 births. From the beginning to the end of the study period, the mean weekly number of births decreased from 1261·1 births (SE 66·1) before lockdown to 651·4 births (49·9) during lockdown—a reduction of 52·4%. The institutional stillbirth rate increased from 14 per 1000 total births before lockdown to 21 per 1000 total births during lockdown (p=0·0002), and institutional neonatal mortality increased from 13 per 1000 livebirths to 40 per 1000 livebirths (p=0·0022). In terms of quality of care, intrapartum fetal heart rate monitoring decreased by 13·4% (−15·4 to −11·3; p<0·0001), and breastfeeding within 1 h of birth decreased by 3·5% (−4·6 to −2·6; p=0·0032). The immediate newborn care practice of placing the baby skin-to-skin with their mother increased by 13·2% (12·1 to 14·5; p<0·0001), and health workers' hand hygiene practices during childbirth increased by 12·9% (11·8 to 13·9) during lockdown (p<0·0001). Interpretation Institutional childbirth reduced by more than half during lockdown, with increases in institutional stillbirth rate and neonatal mortality, and decreases in quality of care. Some behaviours improved, notably hand hygiene and keeping the baby skin-to-skin with their mother. An urgent need exists to protect access to high quality intrapartum care and prevent excess deaths for the most vulnerable health system users during this pandemic period. Funding Grand Challenges Canada.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes

              Background Perform a systematic review and meta-analysis of SARS-CoV-2 infection and pregnancy. Methods Databases (Medline, Embase, Clinicaltrials.gov, Cochrane Library) were searched electronically on 6th April and updated regularly until 8th June 2020. Reports of pregnant women with reverse transcription PCR (RT-PCR) confirmed COVID-19 were included. Meta-analytical proportion summaries and meta-regression analyses for key clinical outcomes are provided. Findings 86 studies were included, 17 studies (2567 pregnancies) in the quantitative synthesis; other small case series and case reports were used to extract rarely-reported events and outcome. Most women (73.9%) were in the third trimester; 52.4% have delivered, half by caesarean section (48.3%). The proportion of Black, Asian or minority ethnic group membership (50.8%); obesity (38.2%), and chronic co-morbidities (32.5%) were high. The most commonly reported clinical symptoms were fever (63.3%), cough (71.4%) and dyspnoea (34.4%). The commonest laboratory abnormalities were raised CRP or procalcitonin (54.0%), lymphopenia (34.2%) and elevated transaminases (16.0%). Preterm birth before 37 weeks’ gestation was common (21.8%), usually medically-indicated (18.4%). Maternal intensive care unit admission was required in 7.0%, with intubation in 3.4%. Maternal mortality was uncommon (~1%). Maternal intensive care admission was higher in cohorts with higher rates of co-morbidities (beta=0.007, p<0.05) and maternal age over 35 years (beta=0.007, p<0.01). Maternal mortality was higher in cohorts with higher rates of antiviral drug use (beta=0.03, p<0.001), likely due to residual confounding. Neonatal nasopharyngeal swab RT-PCR was positive in 1.4%. Interpretation The risk of iatrogenic preterm birth and caesarean delivery was increased. The available evidence is reassuring, suggesting that maternal morbidity is similar to that of women of reproductive age. Vertical transmission of the virus probably occurs, albeit in a small proportion of cases. Funding N/A
                Bookmark

                Author and article information

                Journal
                Lancet Glob Health
                Lancet Glob Health
                The Lancet. Global Health
                The Author(s). Published by Elsevier Ltd.
                2214-109X
                20 November 2020
                February 2021
                20 November 2020
                : 9
                : 2
                : e112
                Affiliations
                [a ]Fetal Medicine Unit, Department of Obstetrics and Gynaecology, St George's Hospital, St George's University of London, London SW17 0RE, UK
                [b ]Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's Hospital, St George's University of London, London SW17 0RE, UK
                [c ]School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK
                [d ]The Royal College of Obstetricians and Gynaecologists, London, UK
                [e ]North Bristol NHS Trust Department of Women's Health, Westbury on Trym, UK
                Article
                S2214-109X(20)30483-6
                10.1016/S2214-109X(20)30483-6
                7833114
                33227255
                de8027cf-0db8-4740-a591-18be1bbb36da
                © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Correspondence

                Comments

                Comment on this article